UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 28, 2009

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 000-10030

Apple Inc.

(Exact name of Registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

Registrant s telephone number, including area code: (408) 996-1010

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months

(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of

Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer,

accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the

Exchange Act).

Yes No

892,109,834 shares of common stock issued and outstanding as of April 13, 2009

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in millions, except share amounts which are reflected in thousands and per share amounts)

Three Months Ended

Six Months Ended

March 28,

2009

March 29,

2008

March 28,

2009

March 29,

2008

Net sales

8,163

7,512

18,330

17,120

Cost of sales

5,192

5,038

11,827

11,314

Gross margin

2,971

2,474

6,503

5,806

Operating expenses:

Research and development

319

273

634

519

Selling, general, and administrative

985

886

2,076

1,846

Total operating expenses

1,304

1,159

2,710

2,365

Operating income

1,667

1,315

3,793

3,441

Other income and expense

63

162

221

362

Income before provision for income taxes

1,730

1,477

4,014

3,803

Provision for income taxes

525

432

1,204

1,177

Net income

1,205

1,045

2,810

2,626

Earnings per common share:

Basic

1.35

1.19

3.16

2.99

Diluted

1.33

1.16

3.11

2.92

Shares used in computing earnings per share:

Basic

891,180

879,546

890,161

877,704

Diluted

902,993

899,329

902,243

899,783

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except share amounts)

March 28,

2009

September 27,

2008

ASSETS:

Current assets:

Cash and cash equivalents

4,466

11,875

Short-term marketable securities

20,547

10,236

Accounts receivable, less allowances of $60 and $47, respectively

1,932

2,422

Inventories

312

509

Deferred tax assets

1,539

1,447

Other current assets

5,057

5,822

Total current assets

33,853

32,311

Long-term marketable securities

3,865

2,379

Property, plant and equipment, net

2,546

2,455

Goodwill

207

207

Acquired intangible assets, net

268

285

Other assets

2,498

1,935

Total assets

43,237

39,572

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

3,976

5,520

Accrued expenses

2,761

3,719

Deferred revenue

7,014

4,853

Total current liabilities

13,751

14,092

Deferred revenue non-current

3,460

3,029

Other non-current liabilities

1,715

1,421

Total liabilities

18,926

18,542

Commitments and contingencies

Shareholders equity:

Common stock, no par value; 1,800,000,000 shares authorized; 891,911,821 and 888,325,973 shares issued and outstanding,

respectively

7,643

7,177

Retained earnings

16,653

13,845

Accumulated other comprehensive income

15

Total shareholders equity

24,311

21,030

Total liabilities and shareholders equity

43,237

39,572

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

Six Months Ended

March 28,

2009

March 29,

2008

Cash and cash equivalents, beginning of the period

11,875

9,352

Operating Activities:

Net income

2,810

2,626

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation, amortization, and accretion

330

222

Stock-based compensation expense

351

242

Deferred income tax (benefit)/expense

(31

Loss on disposition of property, plant, and equipment

10

Changes in operating assets and liabilities:

Accounts receivable, net

490

44

Inventories

197

(18

Other current assets

859

(444

Other assets

(456

(150

Accounts payable

(1,527

(740

Deferred revenue

2,592

1,585

Other liabilities

(844

597

Cash generated by operating activities

4,779

3,980

Investing Activities:

Purchases of marketable securities

(23,483

(12,740

Proceeds from maturities of marketable securities

6,280

6,683

Proceeds from sales of marketable securities

5,457

1,676

Purchases of other long-term investments

(54

(17

Payment for acquisition of property, plant, and equipment

(439

(384

Payment for acquisition of intangible assets

(30

(63

Other

(55

21

Cash used in investing activities

(12,324

(4,824

Financing Activities:

Proceeds from issuance of common stock

122

233

Excess tax benefits from stock-based compensation

47

445

Cash used to net share settle equity awards

(33

(116

Cash generated by financing activities

136

562

Decrease in cash and cash equivalents

(7,409

(282

Cash and cash equivalents, end of the period

4,466

9,070

Supplemental cash flow disclosure:

Cash paid for income taxes, net

1,828

753

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting

Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) design, manufacture,

and market personal computers, portable digital music players, and mobile communication devices and sell a variety of related software, third-party digital content and applications, services, peripherals, and networking solutions. The Company sells

its products worldwide through its online stores, its retail stores, its direct sales force, and third-party wholesalers, resellers, and value-added resellers. In addition, the Company sells a variety of third-party Mac, iPod, and iPhone compatible

products including application software, printers, storage devices, speakers, headphones, and various other accessories and supplies through its online and retail stores. The Company sells to consumer, small and mid-sized business ( SMB ),

education, enterprise, government, and creative markets.

Basis of Presentation and Preparation

The accompanying Condensed Consolidated Financial Statements include the accounts of the Company. Intercompany accounts and transactions have been

eliminated. The accompanying Condensed Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary to present fairly the Condensed Consolidated Financial

Statements for all periods presented. The preparation of these Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts

reported in these Condensed Consolidated Financial Statements and accompanying notes. Actual results could differ materially from those estimates.

Certain prior year amounts in the Condensed Consolidated Financial Statements and notes thereto have been reclassified to conform to the current period s presentation. During the first quarter of 2009, the Company reclassified

$2.4 billion of certain fixed-income securities from short-term marketable securities to long-term marketable securities in the September 27, 2008 Condensed Consolidated Balance Sheet. The reclassification resulted from a change in

accounting presentation for certain investments based on contractual maturity dates, which more closely reflects the Company s assessment of the timing of when such securities will be converted to cash. As a result of this change, marketable

securities with maturities less than 12 months are classified as short-term and marketable securities with maturities greater than 12 months are classified as long-term. There have been no changes in the Company s investment policies or

practices associated with this change in accounting presentation. See Note 2, Financial Instruments of this Form 10-Q for additional information.

These Condensed Consolidated Financial Statements and accompanying notes should be read in conjunction with the Company s annual Consolidated Financial Statements and the notes thereto for the fiscal year ended

September 27, 2008, included in its Annual Report on Form 10-K (the 2008 Form 10-K ). Unless otherwise stated, references to particular years or quarters refer to the Company s fiscal years ended in September and the associated

quarters of those fiscal years.

Earnings Per Common Share

Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per common share

is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been

outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding options, shares to be purchased under the employee stock purchase plan, and unvested restricted stock units ( RSUs ).

The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company s common stock

can result in a greater dilutive effect from potentially dilutive securities.

The following table sets forth the computation of basic and diluted earnings per share for the three- and

six-month periods ended March 28, 2009 and March 29, 2008 (in thousands, except net income in millions and per share amounts):

Three Months Ended

Six Months Ended

March 28,

2009

March 29,

2008

March 28,

2009

March 29,

2008

Numerator:

Net income

1,205

1,045

2,810

2,626

Denominator:

Weighted-average shares outstanding

891,180

879,546

890,161

877,704

Effect of dilutive securities

11,813

19,783

12,082

22,079

Denominator for diluted earnings per share

902,993

899,329

902,243

899,783

Basic earnings per share

1.35

1.19

3.16

2.99

Diluted earnings per share

1.33

1.16

3.11

2.92

Potentially dilutive securities representing approximately 19.2 million and 12.3 million

shares of common stock for the three months ended March 28, 2009 and March 29, 2008, respectively, and 18.0 million and 8.6 million shares of common stock for the six months ended March 28, 2009 and March 29, 2008,

respectively, were excluded from the computation of diluted earnings per share for these periods because their effect would have been antidilutive.

Fair Value Measurements

During the first quarter of 2009, the Company adopted Financial Accounting Standards Board

( FASB ) Statement of Financial Accounting Standards ( SFAS ) No. 157, Fair Value Measurements, which defines fair value, establishes guidelines for measuring fair value and expands disclosures regarding fair value

measurements. SFAS No. 157 does not require any new fair value measurements, but rather eliminates inconsistencies in guidance found in various other accounting pronouncements. The adoption of SFAS No. 157 did not have a material effect on

the Company s financial condition or operating results.

SFAS No. 157 establishes a hierarchy for information and valuations used

in measuring fair value, which is broken down into three levels. Level 1 valuations are based on quoted prices in active markets for identical assets or liabilities. Level 2 valuations are based on inputs that are observable, either directly or

indirectly, other than quoted prices included within Level 1. Level 3 valuations are based on information that is unobservable and significant to the overall fair value measurement.

The Company also adopted SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities including an amendment of FASB Statement No. 115, during the

first quarter of 2009. SFAS No. 159 allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. SFAS No. 159 requires that unrealized

gains and losses on items for which the fair value option has been elected be reported in earnings at each reporting date. The Company adopted SFAS No. 159 but has not elected the fair value option for any eligible financial instruments.

Refer to Note 3, Fair Value Measurements of this Form 10-Q for additional information on the adoption of SFAS Nos. 157 and

159.

Derivative Financial Instruments

During the second quarter of 2009, the Company adopted SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities an amendment of FASB Statement No. 133, which requires additional disclosures about

the Company s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for under SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities,

and related interpretations, and how the derivative instruments and related hedged items affect the financial statements. The adoption of SFAS No. 161 had no financial impact on the Company s Condensed Consolidated Financial Statements.

Refer to Note 2, Financial Instruments of this Form 10-Q for additional information on the adoption of SFAS No. 161.

Note 2 Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following table summarizes the fair value of

the Company s cash and available-for-sale securities held in its marketable securities investment portfolio, recorded as cash, cash equivalents, short-term or long-term marketable securities as of March 28, 2009 and September 27, 2008

(in millions):

March 28, 2009

September 27, 2008

Cash

622

368

Money market funds

1,808

1,536

U.S. Treasury securities

340

118

U.S. agency securities

777

2,798

Certificates of deposit and time deposits

610

2,560

Commercial paper

309

4,429

Corporate securities

66

Total cash equivalents

3,844

11,507

U.S. Treasury securities

1,116

343

U.S. agency securities

15,632

5,823

Non-U.S. government securities

54

83

Certificates of deposit and time deposits

196

486

Commercial paper

1,295

1,254

Corporate securities

2,249

2,247

Municipal securities

Total short-term marketable securities

20,547

10,236

U.S. Treasury securities

195

100

U.S. agency securities

1,375

751

Certificates of deposit and time deposits

32

Corporate securities

2,232

1,496

Municipal securities

63

Total long-term marketable securities

3,865

2,379

Total cash, cash equivalents and marketable securities

28,878

24,490

As of December 27, 2008, the Company changed its accounting presentation for certain

fixed-income investments, which resulted in the reclassification of certain investments from short-term marketable securities to long-term marketable securities. As a result, prior period balances have been reclassified to conform to the current

period s presentation. The Company classifies its marketable securities as either short-term or long-term based on each instrument s underlying contractual maturity date, while its prior classifications were based on the nature of the

securities and their availability for use in current operations. As a result of this change, marketable securities with maturities of less than 12 months are classified as short-term and marketable securities with maturities greater than 12 months

are classified as long-term. The Company s long-term marketable securities maturities range from one year to five years. The Company believes this new presentation is preferable as it more closely reflects the Company s assessment of

the timing of when such securities will be converted to cash. Accordingly, certain fixed-income investments totaling $2.4 billion have been reclassified from short-term marketable securities to long-term marketable securities in the

September 27, 2008 Condensed Consolidated Balance Sheet to conform to the current period s financial statement presentation. There have been no changes in the Company s investment policies or practices associated with this change in

accounting presentation.

The Company had net unrealized losses on its investment portfolio of $69 million and $117 million as of

March 28, 2009 and September 27, 2008, respectively. In both periods, the net unrealized losses related primarily to long-term marketable securities. The Company may sell certain of its marketable securities prior to their stated

maturities for strategic purposes, in anticipation of credit deterioration, or for duration management. The Company recognized no material net gains or losses during the three- and six-month periods ended March 28, 2009 and March 29, 2008

related to such sales.

The following table shows the gross unrealized losses and fair value for investments in an unrealized loss position

as of March 28, 2009 and September 27, 2008, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions):

March 28, 2009

Less than 12 Months

12 Months or Greater

Total

Security Description

Fair

Value

Unrealized

Loss

Fair

Value

Unrealized

Loss

Fair

Value

Unrealized

Loss

U.S. agency securities

2,375

(2

2,375

(2

Corporate securities

1,422

(16

1,109

(106

2,531

(122

Total

3,797

(18

1,109

(106

4,906

(124

September 27, 2008

Less than 12 Months

12 Months or Greater

Total

Security Description

Fair

Value

Unrealized

Loss

Fair

Value

Unrealized

Loss

Fair

Value

Unrealized

Loss

U.S. agency securities

6,822

(13

6,822

(13

Corporate securities

2,147

(31

1,148

(77

3,295

(108

Total

8,969

(44

1,148

(77

10,117

(121

The Company considers the declines in market value of its marketable securities investment

portfolio to be temporary in nature. The unrealized losses on the Company s marketable securities were caused primarily by changes in market interest rates, specifically, widening credit spreads. The Company typically invests in highly-rated

securities, and its policy generally limits the amount of credit exposure to any one issuer. The Company s investment policy requires investments to be rated single-A or better, with the objective of minimizing the potential risk of principal

loss. Fair values were determined for each individual security in the investment portfolio. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value

has been below cost basis, the financial condition of the issuer, and the Company s ability and intent to hold the investment for a period of time, which may be sufficient for anticipated recovery in market value. During the three- and

six-month periods ended March 28, 2009 and March 29, 2008, the Company did not recognize any material impairment charges on outstanding securities. As of March 28, 2009, the Company does not consider any of its investments to be

other-than-temporarily impaired.

Derivative Financial Instruments

The Company uses derivatives to partially offset its business exposure to foreign exchange risk. The Company may enter into foreign currency forward and option contracts to offset some of the foreign exchange risk of

expected future cash flows on certain forecasted revenue and cost of sales, of net investments in certain foreign subsidiaries, and on certain existing assets and liabilities. To help protect gross margins from fluctuations in foreign currency

exchange rates, certain of the Company s subsidiaries whose functional currency is the U.S. dollar, hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who

sell in local currencies, may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with

revenue and inventory purchases for three to six months. To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to

offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. The Company may also enter into foreign currency forward and option contracts to partially offset the foreign exchange gains and

losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge

certain foreign exchange exposures for a variety of reasons, including but not limited to immateriality, accounting considerations, and the prohibitive

economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange rates. As of the end of the second quarter of 2009, the general

nature of the Company s risk management activities and the general nature and mix of the Company s derivative financial instruments have not changed materially from the end of 2008.

The Company s accounting policies for these instruments are based on whether the instruments are designated as hedge or non-hedge instruments in accordance with SFAS No. 133. The

Company records all derivatives on the balance sheet at fair value. The effective portions of cash flow hedges are recorded in other comprehensive income until the hedged item is recognized in earnings. The effective portions of net investment

hedges are recorded in other comprehensive income as a part of the cumulative translation adjustment. Derivatives that are not designated as hedging instruments and the ineffective portions of cash flow hedges and net investment hedges are adjusted

to fair value through earnings in other income and expense.

The Company had a net deferred gain associated with cash flow hedges of

approximately $72 million and $19 million, net of taxes, recorded in other comprehensive income as of March 28, 2009 and September 27, 2008, respectively. Other comprehensive income associated with cash flow hedges of foreign currency

revenue is recognized as a component of net sales in the same period as the related revenue is recognized, and other comprehensive income related to cash flow hedges of inventory purchases is recognized as a component of cost of sales in the same

period as the related costs are recognized. The portion of the Company s net deferred gain related to products under subscription accounting is expected to be recorded in earnings ratably over the related products estimated economic lives

beginning when the hedged transactions occur, while the portion of the net deferred gain related to other products is expected to be recorded in earnings at the time the hedged transactions occur. As of March 28, 2009, the hedged transactions

are expected to occur within six months.

Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is

probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two month time period. Deferred gains and losses in other comprehensive income associated with such derivative instruments are

reclassified immediately into earnings through other income and expense. Any subsequent changes in fair value of such derivative instruments also are reflected in current earnings unless they are re-designated as hedges of other transactions. The

Company did not recognize any material net gains related to the loss of hedge designation on discontinued cash flow hedges during the three- and six-month periods ended March 28, 2009 and March 29, 2008, respectively.

The Company had an unrealized net gain on net investment hedges of $6 million, net of tax, and an unrealized net loss on net investment hedges of $1

million, net of tax, included in the cumulative translation adjustment account of accumulated other comprehensive income ( AOCI ) as of March 28, 2009 and September 27, 2008, respectively. The ineffective portions and amounts

excluded from the effectiveness test of net investment hedges are recorded in current earnings in other income and expense.

The Company

recognized in earnings a total net gain on foreign currency forward and option contracts not designated as hedging instruments in accordance with SFAS No. 133 of $15 million and $173 million during the three- and six-month periods ended

March 28, 2009, respectively.

The following table shows the notional principal and credit risk amounts of the Company s derivative

instruments as of March 28, 2009 (in millions):

March 28, 2009

Notional

Principal

Credit Risk

Amounts

Instruments qualifying as accounting hedges:

Foreign exchange contracts

2,981

75

Instruments other than accounting hedges:

Foreign exchange contracts

2,351

29

The notional principal amounts for derivative instruments provide one measure of the transaction

volume outstanding as of March 28, 2009, and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts shown in the table above represent the Company s gross exposure to potential

accounting loss on these transactions if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates. The Company s exposure to credit loss and market risk will vary over time as a

function of currency exchange rates. Although the table above reflects the notional principal and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and

transactions that the foreign exchange instruments are intended to hedge. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market

conditions during the remaining life of the instruments.

The estimates of fair value are based on applicable and commonly used pricing

models and prevailing financial market information as of March 28, 2009. Refer to Note 3, Fair Value Measurements of this Form 10-Q, for additional information on the fair value measurements for all financial assets and liabilities,

including derivative assets and derivative liabilities, that are measured at fair value in the Condensed Consolidated Financial Statements on a recurring basis. The following table shows the Company s derivative instruments measured at gross

fair value as reflected in the Condensed Consolidated Balance Sheet as of March 28, 2009 (in millions):

March 28, 2009

Fair Value of

Derivatives Designated

as Hedge Instruments

Fair Value of Derivatives

Not Designated as Hedge

Instruments

Derivative assets (a):

Foreign exchange contracts

70

30

Derivative Liabilities (b):

Foreign exchange contracts

34

16

(a)

All derivative assets are recorded as other current assets in the Condensed Consolidated Balance Sheet.

(b)

All derivative liabilities are recorded as accrued expenses in the Condensed Consolidated Balance Sheet.

10

The following tables show the effect of the Company s derivative instruments designated as cash flow

and net investment hedges in the Condensed Consolidated Statement of Operations for the three- and six-month periods ended March 28, 2009 (in millions):

Three Months Ended March 28, 2009

Gain or (Loss)

Recognized in

AOCI -

Effective

Portion (a)

Location of

Gain or (Loss)

Reclassified

from AOCI into

Income -

Effective

Portion

Gain or (Loss)

Reclassified

from AOCI

into Income -

Effective

Portion (a)

Location of Gain

or (Loss)

Recognized

Ineffective

Portion and

Amount Excluded

from

Effectiveness

Testing

Gain or (Loss)

Recognized -

Ineffective Portion

and Amount

Excluded from

Effectiveness

Testing

Cash flow hedges:

Foreign exchange contracts

27

Net sales

79

Other income and expense

(28

Foreign exchange contracts

27

Cost of sales

25

Other income and expense

(6

Net investment hedges:

Foreign exchange contracts

16

Other income and expense

Other income and expense

Total

70

104

(34

Six Months Ended March 28, 2009

Gain or (Loss)

Recognized in

AOCI -

Effective

Portion (a)

Location of

Gain or (Loss)

Reclassified

from AOCI into

Income -

Effective

Portion

Gain or (Loss)

Reclassified

from AOCI

into Income -

Effective

Portion (a)

Location of Gain

or (Loss)

Recognized

Ineffective

Portion and

Amount Excluded

from

Effectiveness

Testing

Gain or (Loss)

Recognized -

Ineffective Portion

and Amount

Excluded from

Effectiveness

Testing

Cash flow hedges:

Foreign exchange contracts

298

Net sales

240

Other income and expense

(51

Foreign exchange contracts

123

Cost of sales

97

Other income and expense

(5

Net investment hedges:

Foreign exchange contracts

(22

Other income and expense

Other income and expense

Total

399

337

(54

(a)

Refer to Note 6, Shareholders Equity of this Form 10-Q, which summarizes the activity in other comprehensive income related to derivatives.

Note 3 Fair Value Measurements

In the first quarter of 2009, the Company adopted SFAS No. 157 for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the financial

statements on a recurring basis. SFAS No. 157 defines fair value as the price that would be received from selling an asset or paid to transfer a

11

liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and

liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would

use in pricing the asset or liability, such as inherent risk, transfer restrictions, and credit risk.

SFAS No. 157 also establishes a

fair value hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three levels. A financial instrument s categorization within the fair value hierarchy is based upon the lowest level of input that is

available and significant to the fair value measurement. SFAS No. 157 establishes and prioritizes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 -

Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by

observable market data for substantially the full term of the assets or liabilities.

Level 3 - Inputs that are generally

unobservable and typically reflect management s estimates of assumptions that market participants would use in pricing the asset or liability.

Assets/Liabilities Measured at Fair Value on a Recurring Basis

The following table presents the Company s assets and

liabilities measured at fair value on a recurring basis as of March 28, 2009 (in millions):

March 28, 2009

Quoted Prices

in Active

Markets for

Identical